Japanese Venture Announces World's First iPS Cell Transplant Trial for Spinal Cord Injury

A venture company from Keio University in Japan announced plans for the world's first clinical trial to transplant nerve cells derived from iPS cells into patients with spinal cord injuries, with a potential start as early as December next year.